CHEMED CORP (CHE) › Shareholders' EquityCHEMED CORP (CHE) — Shareholders' EquityAnnual figures by period end, from SEC filings.2009-12-31: $477.16M2010-12-31: $462.05M2011-12-31: $413.68M2012-12-31: $453.29M2013-12-31: $448.89M2014-12-31: $451.36M2015-12-31: $513.25M2016-12-31: $524.10M2017-12-31: $540.35M2018-12-31: $591.33M2019-12-31: $726.61M2020-12-31: $901.20M2021-12-31: $623.27M2022-12-31: $798.72M2023-12-31: $1.11B2024-12-31: $1.12B2025-12-31: $979.40M$979.40M2009-12-31Shareholders' Equity (USD)2025-12-31Period endedShareholders' EquityChange YoYSource filing2025-12-31$979.40M-12.5%2026-02-27Balance as of period end2024-12-31$1.12B+1.0%2026-02-27Balance as of period end2023-12-31$1.11B+38.7%2026-02-27Balance as of period end2022-12-31$798.72M+28.1%2026-02-27Balance as of period end2021-12-31$623.27M-30.8%2025-02-28Balance as of period end2020-12-31$901.20M+24.0%2024-02-29Balance as of period end2019-12-31$726.61M+22.9%2023-02-27Balance as of period end2018-12-31$591.33M+9.4%2022-02-28Balance as of period end2017-12-31$540.35M+3.1%2021-02-26Balance as of period end2016-12-31$524.10M+2.1%2020-02-26Balance as of period end2015-12-31$513.25M+13.7%2019-02-27Balance as of period end2014-12-31$451.36M+0.5%2018-02-26Balance as of period end2013-12-31$448.89M-1.0%2017-02-27Balance as of period end2012-12-31$453.29M+9.6%2016-02-26Balance as of period end2011-12-31$413.68M-10.5%2013-02-27Balance as of period end2010-12-31$462.05M-3.2%2012-02-27Balance as of period end2009-12-31$477.16M—2011-02-28Balance as of period endOther metrics: RevenueCost of RevenueGross ProfitOperating IncomeNet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesCash & EquivalentsOperating Cash FlowCapital ExpendituresShares OutstandingDividends Per ShareWeighted Average Diluted SharesEPS (Basic)